Computational design of constitutively active cGAS.
Dowling, Q.M., Volkman, H.E., Gray, E.E., Ovchinnikov, S., Cambier, S., Bera, A.K., Sankaran, B., Johnson, M.R., Bick, M.J., Kang, A., Stetson, D.B., King, N.P.(2023) Nat Struct Mol Biol 30: 72-80
- PubMed: 36593311 
- DOI: https://doi.org/10.1038/s41594-022-00862-z
- Primary Citation of Related Structures:  
7KXS, 7LZ3 - PubMed Abstract: 
Cyclic GMP-AMP synthase (cGAS) is a pattern recognition receptor critical for the innate immune response to intracellular pathogens, DNA damage, tumorigenesis and senescence. Binding to double-stranded DNA (dsDNA) induces conformational changes in cGAS that activate the enzyme to produce 2'-3' cyclic GMP-AMP (cGAMP), a second messenger that initiates a potent interferon (IFN) response through its receptor, STING. Here, we combined two-state computational design with informatics-guided design to create constitutively active, dsDNA ligand-independent cGAS (CA-cGAS). We identified CA-cGAS mutants with IFN-stimulating activity approaching that of dsDNA-stimulated wild-type cGAS. DNA-independent adoption of the active conformation was directly confirmed by X-ray crystallography. In vivo expression of CA-cGAS in tumor cells resulted in STING-dependent tumor regression, demonstrating that the designed proteins have therapeutically relevant biological activity. Our work provides a general framework for stabilizing active conformations of enzymes and provides CA-cGAS variants that could be useful as genetically encoded adjuvants and tools for understanding inflammatory diseases.
Organizational Affiliation: 
Department of Bioengineering, University of Washington, Seattle, WA, USA.